Article Information
History
- November 13, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Makyao Minja1,
- Tusaligwe Mbilinyi2,
- Bryceson Mkinga3,
- Erick G. Philipo4,
- Joyce Owenya5 and
- Manase Kilonzi1,*
- 1Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, the Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
- 2Department of Pharmaceutical Microbiology, School of Pharmacy, the Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
- 3Department of Pharmacognosy, School of Pharmacy, the Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
- 4Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, the Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
- 5Department of Pharmacy, Temeke Regional Referral Hospital, Dar es Salaam, Tanzania
- ↵*Corresponding author: manasekilonzi{at}gmail.com, +255 688 045752
Posted November 13, 2023.
Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among people living with HIV in Tanzania
